links to articles and videos
Why It’s Unwise to Inhibit Nerve Growth Factor
Wonder Drug or Disaster in the Making?
https://www.dogsnaturallymagazine.com/librela-berensa-wonder-drug-or-disaster-in-the-making/
French:
Librela (Beransa) – Médicament Miracle ou Désastre en Puissance? Aussi vendu pour chats sous le nom de Solensia
German:
Librela (Beransa) – Wunderdroge oder bevorstehende Katastrophe?
https://www.hundeportal24.eu/gesundheit/librela-beransa-wunderdroge-oder-bevorstehende-katastrophe/
What about Librela, Anti-Nerve Growth Factor Antibody Treatment?
Librela: Should you believe the hype?
LIBRELA: How to Evaluate New Pharmaceuticals and Medical Products
Side effects in the product package inserts
Side Effects Published by Zoetis
Many pet parents have reported they were told this product has "no side effects". The image on the left is a consolidated list of side effects published in the product package inserts.
‘It’s horrible:’ Second C.O. dog owner tells NewsChannel 21 of tragic experience with prescribed drug Librela
“I don’t know what cases they’re not right for. That’s something we learn over time.”
Dr. Duncan Lascelles, a professor of translational pain research and management at North Carolina State University’s College of Veterinary Medicine who helped Zoetis design Solensia studies.
Wall Street Journal Article dated April 12, 2024
Link to the article on MSN:
Investigation of Zoetis on behalf of investors
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm | Markets Insider https://markets.businessinsider.com/news/stocks/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-zoetis-inc-and-encourages-investors-with-losses-to-contact-the-firm-1033290628
Human trials of NGF-blocker for treatment of arthritis pain
FDA panel rejects Pfizer's tanezumab for osteoarthritis pain over risk-benefit doubts
“So, why would we approve a drug treatment for osteoarthritis that’s minimally better than placebo, no better than existing therapies like aspirin and anti-inflammatories, has a worse risk profile than placebo and existing therapies, and poses a risk to non-target joints with irreversible damage — to the point that we are tussling with this Risk Evaluation and Mitigation Strategy program, which in my opinion is more accurately a post-marketing surveillance program?”
- Edward Y. Cheng, MD, of the University of Minnesota Medical School
Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Tanezumab Out of its Misery
Are Zoetis and Pfizer the same?
The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries.
https://www.nasdaq.com/articles/why-zoetis-is-the-pfizer-of-animal-healthcare-2021-03-16